Drugs / Lignosus rhinoceros
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06451328 | Mar 2022 → Feb 2023 | asthma | University of Malaya | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lignosus rhinoceros | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06451328 ↗ |
| Known as | TM02 | “Lignosus rhinoceros TM02®” NCT06451328 ↗ |